GlassScriptPhysician profile
Norman M Ramirez
NPI 1871532531
$15,814.52
in general payments reported to CMS, 2019-2025
12 companies · $817 in 2025
The $817 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,424 · 2020: $445 · 2021: $854 · 2022: $2,695 · 2023: $3,935 · 2024: $1,646 · 2025: $817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,244 · Food and Beverage: $3,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,244.20 |
| Food and Beverage | $3,153.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,765.20 | 2019-2025 | Mitraclip, Amplatzer Amulet, Cardiomems |
| Medtronic, INC. | $2,620.98 | 2021-2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan, Cg Future |
| Silk Road Medical, INC. | $1,612.74 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $1,315.59 | 2019-2025 | Watchman Flx, Watchman |
| Medtronic Vascular, INC. | $300.21 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $93.91 | 2023-2025 | Optimizer |
| Arrow International, INC. | $50.35 | 2019 | |
| Pfizer INC. | $23.70 | 2024 | |
| Janssen Pharmaceuticals, INC | $20.64 | 2023 | Xarelto |
| Angiodynamics, INC. | $11.20 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.